Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q1 2021 | 2021-05-10 | Future report Set alerts | |
Q4 2020 | 2021-03-01 | -0.43 | -0.43 |
Q3 2020 | 2020-11-02 | 0.00 | 0.00 |
Q2 2020 | 2020-08-10 | 0.29 | 0.29 |
Q1 2020 | 2020-05-11 | -0.35 | -0.35 |
Q4 2019 | 2020-03-10 | -0.26 | -0.26 |
Q3 2019 | 2019-11-04 | -0.22 | -0.22 |
Q2 2019 | 2019-08-05 | -0.26 | -0.26 |
Q1 2019 | 2019-05-06 | -0.23 | -0.23 |
Q4 2018 | 2019-03-11 | -0.21 | -0.21 |
2016-05-19 | Reiterated Rating | Cowen and Company | Hold | |
2016-03-14 | Reiterated Rating | Cowen and Company | Hold | |
2016-01-07 | Reiterated Rating | Cowen and Company | Market Perform | |
2015-09-24 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
2015-05-18 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $7.00 to $14.00 |
2014-11-06 | Downgrade | Cowen and Company | Outperform to Market Perform | |
2014-01-13 | Initiated Coverage | Goldman Sachs | Neutral | $7.00 |
2013-12-04 | Downgrade | Citigroup Inc. | Buy to Neutral | |
2012-11-14 | Initiated | Stifel Nicolaus | Buy | $16 |
2016-05-19 | Reiterated Rating | Cowen and Company | Hold | |
2016-03-14 | Reiterated Rating | Cowen and Company | Hold | |
2016-01-07 | Reiterated Rating | Cowen and Company | Market Perform | |
2015-09-24 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
2015-05-18 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $7.00 to $14.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CCXI 151 funds of 2210 total. Show all
Fund name | Ticker shares |
---|---|
FMR LLC | 10.38M |
WELLINGTON MANAGEMENT CO LLP | 6.15M |
BlackRock Inc. | 4.80M |
RA CAPITAL MANAGEMENT, LLC | 4.78M |
Vanguard Group, Inc | 4.75M |
STATE STREET CORP | 2.01M |
BlackRock Fund Advisors | 1.41M |
PICTET ASSET MANAGEMENT LTD | 1.24M |
Cormorant Asset Management, LLC | 1.20M |
WASATCH ADVISORS INC | 1.11M |
MACQUARIE GROUP LTD | 1.02M |
Invesco Ltd. | 0.97M |
GEODE CAPITAL MANAGEMENT, LLC | 0.79M |
LOOMIS SAYLES & CO L P | 0.76M |
GOLDMAN SACHS GROUP INC | 0.76M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Schall Thomas J. President and CEO | 5.04% (2184994) | CCXI / |
Edwards Thomas A. | 0.32% (138785) | CCXI / |
LUCAS ROGER C | 0.22% (93846) | CCXI / TECH / |
FECZKO JOSEPH M | 0.19% (82096) | CCXI / KERX / |
Bekker Petrus SVP of Medical & Clinical | 0.14% (59839) | CCXI / |
Tyree James L | 0.12% (53849) | CCXI / DEPO / THRX / |
Parker Geoffrey M. | 0.11% (45671) | ANAC / CCXI / GHDX / PRGO / SNSS / |
MCKINNELL HENRY A | 0.10% (44218) | CCXI / MCO / |
KANAYA SUSAN M SVP, Finance, CFO and Sec. | 0.09% (38135) | CCXI / |
Jaen Juan C. SVP, Drug Discovery & CSO | 0.07% (30000) | CCXI / |
Cappel Markus J. Chief Bus. Officer & Treasurer | 0.05% (23826) | CCXI / |
KLEIN IRA | 0.04% (16216) | CCXI / |
SINGH RAJINDER SVP, Research | 0.02% (10000) | CCXI / |